Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-29

FDA Approved: CYTALUX — Original Application (On Target Laboratories, Inc.)

View source ↗

Summary

The FDA approved Cytalux (pafolacianine injection) from On Target Laboratories for intraoperative visualization of folate receptor–positive ovarian cancer to ai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cytalux (pafolacianine)

Snippet

ORIG AP for CYTALUX (PAFOLACIANINE INJECTION)